Related Experiment Video
Updated: Feb 8, 2026

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
Modulation of the gamma-secretase activity as a therapy against human hepatocellular carcinoma
Yuqing Shen1, Ying Yin2, Yaqin Peng1
1Department of Microbiology and Immunology, Key Laboratory of Developmental Genes and Human Disease, Ministry of Education, Medical School, Southeast University, Nanjing, Jiangsu Province, China.
Objective:
Hepatocellular carcinoma (HCC) is the fifth most common tumor worldwide. The discovery of new therapies against HCC is highly dependable on finding molecules which play essential roles in cancer development. The objective of this study was to evaluate the activity of gamma secretase (γ-secretase), and the antitumor effects of a γ-secretase inhibitor (GSI) in HCC.
Methods:
The expression of presenilin 1 (PS1), a core component of γ-secretase, was examined by Western blot. Activity of γ-secretase was measured by a luciferase-based reporter system, and cancer cells were transfected either with PS1 dominant negative mutant (PS1D385A) or treated with GSI.
Results:
Expression of PS1 was increased in HCC tissue and several HCC cell lines, which were accompanied by elevated γ-secretase activity. Cell colony formation and cell proliferation were decreased upon treatment with GSI but not with PS1D385A transfection.
Conclusion:
GSIs may be appealing candidates for the development of new therapies against HCC.
Insights
Gamma secretase inhibitors (GSIs) show promise for treating hepatocellular carcinoma (HCC). This study found that inhibiting gamma secretase activity reduced HCC cell growth and colony formation.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Hepatocellular carcinoma (HCC) is a significant global health concern.
- Identifying novel therapeutic targets is crucial for advancing HCC treatment.
- Gamma-secretase (γ-secretase) plays a role in cancer development.
Purpose of the Study:
- To investigate the activity of γ-secretase in HCC.
- To evaluate the antitumor effects of γ-secretase inhibitors (GSIs) in HCC models.
Main Methods:
- Western blot analysis was used to assess presenilin 1 (PS1) expression.
- A luciferase reporter system measured γ-secretase activity.
- HCC cells were treated with a GSI or transfected with a PS1 dominant-negative mutant.
Main Results:
- PS1 expression and γ-secretase activity were elevated in HCC tissues and cell lines.
- GSI treatment significantly decreased HCC cell colony formation and proliferation.
- PS1 dominant-negative mutant transfection did not affect cell growth.
Conclusions:
- Elevated γ-secretase activity is associated with HCC.
- GSIs demonstrate potential as a therapeutic strategy for HCC.
- Targeting γ-secretase warrants further investigation for HCC treatment.
More Related Videos
05:06A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
Related Concept Videos
Gene Therapy
Group Therapy
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Behavior Therapy
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...
Drug Therapy
Antianxiety Medications
Cognitive Therapy